Edwards Lifesciences (EW) Amortizatization of Intangibles (2021 - 2026)
Edwards Lifesciences (EW) posted Amortizatization of Intangibles of $6.6 million for Q2 2026, up 1.54% on a QoQ basis from $6.5 million in Q1 2026, and up 3.12% year-over-year from $6.4 million in Q2 2025.
Analysis
Edwards Lifesciences (EW) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Edwards Lifesciences has reported Amortizatization of Intangibles for 6 years, with the latest figure at $6.6 million in Q2 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 3.12% year-over-year to $6.6 million in Q2 2026; TTM through Jun 2026 was $26.5 million, a 5.16% increase from a year earlier, with the FY2025 full-year figure at $25.9 million, down 6.83% from the prior year.
- Amortizatization of Intangibles was $6.6 million for Q2 2026 at Edwards Lifesciences, up from $6.5 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $7.7 million in Q1 2024, with the low at $6.1 million in Q1 2025.
- Average Amortizatization of Intangibles over 5 years is $6.8 million, with a median of $6.8 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles climbed 13.64% in 2023, then slipped 20.78% in 2025.
- Over 5 years, Amortizatization of Intangibles stood at $6.6 million in 2022, then grew by 13.64% to $7.5 million in 2023, then dropped by 17.33% to $6.2 million in 2024, then grew by 6.45% to $6.6 million in 2025, then changed by 0.0% to $6.6 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $6.6 million (Q2 2026), $6.5 million (Q1 2026), and $6.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 38.80 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.60 Mn |
| Mar 31, 2026 | 6.50 Mn |
| Dec 31, 2025 | 6.60 Mn |
| Sep 30, 2025 | 6.80 Mn |
| Jun 30, 2025 | 6.40 Mn |
| Mar 31, 2025 | 6.10 Mn |
| Dec 31, 2024 | 6.20 Mn |
| Sep 30, 2024 | 6.50 Mn |
| Jun 30, 2024 | 7.40 Mn |
| Mar 31, 2024 | 7.70 Mn |
| Dec 31, 2023 | 7.50 Mn |
| Sep 30, 2023 | 7.00 Mn |
| Jun 30, 2023 | 6.90 Mn |
| Mar 31, 2023 | 6.80 Mn |
| Dec 31, 2022 | 6.60 Mn |
| Sep 30, 2022 | 6.70 Mn |
| Jun 30, 2022 | 6.80 Mn |
| Mar 31, 2022 | 7.10 Mn |
| Dec 31, 2021 | 7.10 Mn |
| Sep 30, 2021 | 7.10 Mn |